COVID-19 in children: Could pertussis vaccine play the protective role?

Area of Science:

• Immunology
• Infectious Diseases
• Pediatrics

Background:

• COVID-19 disproportionately affects adults, with children exhibiting milder symptoms, suggesting potential protective factors.
• Pertussis (whooping cough) shares respiratory transmission and clinical features with COVID-19, despite differing causative agents (bacterium vs. virus).

Purpose of the Study:

• To propose and explore the hypothesis that childhood pertussis vaccination may confer non-specific protection against COVID-19 in pediatric populations.
• To investigate the potential role of heterologous adaptive responses in mediating cross-protection between pertussis and SARS-CoV-2 infections.

Main Methods:

• Theoretical argumentation based on existing immunological principles and empirical data.
• Review of literature on cross-reactivity and heterologous immunity between unrelated pathogens.
• Outline of proposed research methodologies from various scientific disciplines to test the hypothesis.

Main Results:

• The study presents a hypothesis, not empirical results.
• Theoretical evidence suggests that heterologous adaptive responses can occur between diverse agents like bacteria and viruses.
• Potential mechanisms for non-specific protection are discussed.

Conclusions:

• Childhood pertussis vaccination is hypothesized to offer a non-specific protective effect against COVID-19 in children.
• Further research is needed to validate this hypothesis and explore its public health implications.
• Potential concerns regarding the implementation of this strategy as a public health intervention are acknowledged.